Related symptoms may include gastrointestinal upset, brittle nails, hair loss, and in more severe cases, neurological effects [92]
Tirzepatide, the active ingredient in Mounjaro, is a dual GLP-1 and GIP receptor agonist now widely used for weight loss and blood sugar control
Lipotropic compounds support hepatic fat metabolism through methionine, inositol, and choline pathways, while tirzepatide acts as a dual GIP/GLP-1 receptor agonist that delays gastric emptying and reduces appetite signaling
When people stop taking semaglutide or tirzepatide, appetite hormones like ghrelin rebound, hunger signals return to baseline levels, and the metabolic advantage from the drug disappears within weeks
The goal is to lose weight whilst maintaining health